These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10928955)

  • 1. Regulation of lymphocyte proliferation by eosinophils via chymotrypsin-like protease activity and adhesion molecule interaction.
    Matsunaga Y; Shono M; Takahashi M; Tsuboi Y; Ogawa K; Yamada T
    Br J Pharmacol; 2000 Aug; 130(7):1539-46. PubMed ID: 10928955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human eosinophil cationic proteins (ECP and EPX) and their suppressive effects on lymphocyte proliferation.
    Peterson CG; Skoog V; Venge P
    Immunobiology; 1986 Mar; 171(1-2):1-13. PubMed ID: 2940166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of chymotrypsin-like proteases inhibit eosinophil peroxidase release from activated human eosinophils.
    Matsunaga Y; Kido H; Kawaji K; Kamoshita K; Katunuma N; Ogura T
    Arch Biochem Biophys; 1994 Jul; 312(1):67-74. PubMed ID: 8031148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of eosinophil cationic protein release in the serum: role of adhesion molecules.
    Kato Y; Fujisawa T; Terada A; Iguchi K; Kamiya H
    Int Arch Allergy Immunol; 1999; 120 Suppl 1():60-4. PubMed ID: 10529607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD11b/CD18 (Mac-1) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor.
    Horie S; Kita H
    J Immunol; 1994 Jun; 152(11):5457-67. PubMed ID: 7514638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist.
    Simon HU; Weber M; Becker E; Zilberman Y; Blaser K; Levi-Schaffer F
    J Immunol; 2000 Oct; 165(7):4069-75. PubMed ID: 11034418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
    Takafuji S; Ohtoshi T; Takizawa H; Tadokoro K; Ito K
    J Immunol; 1996 May; 156(10):3980-5. PubMed ID: 8621939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
    Takafuji S; Tadokoro K; Ito K; Nakagawa T
    Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
    Xu X; Håkansson L
    Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of eosinophil peroxidase release by chymotrypsin type protease inhibitors from activated human eosinophils].
    Kawaji K; Matsunaga Y; Kido H; Ogura T
    Arerugi; 1993 Oct; 42(10):1591-9. PubMed ID: 8250722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophil granule proteins activate human heart mast cells.
    Patella V; de Crescenzo G; Marinò I; Genovese A; Adt M; Gleich GJ; Marone G
    J Immunol; 1996 Aug; 157(3):1219-25. PubMed ID: 8757629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.
    Olszewska-Pazdrak B; Pazdrak K; Ogra PL; Garofalo RP
    J Immunol; 1998 May; 160(10):4889-95. PubMed ID: 9590236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of pemirolast, a novel antiallergic drug, on leukotriene C4 and granule protein release from human eosinophils.
    Kawashima T; Iwamoto I; Nakagawa N; Tomioka H; Yoshida S
    Int Arch Allergy Immunol; 1994; 103(4):405-9. PubMed ID: 8130655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
    Egesten A; Blom M; Calafat J; Janssen H; Knol EF
    Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of loratadine on human eosinophil function in vitro.
    Eda R; Sugiyama H; Hopp RJ; Bewtra AK; Townley RG
    Ann Allergy; 1993 Oct; 71(4):373-8. PubMed ID: 8214802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-activating factor stimulates cytoplasmic alkalinization and granule acidification in human eosinophils.
    Bankers-Fulbright JL; Kephart GM; Bartemes KR; Kita H; O'Grady SM
    J Cell Sci; 2004 Nov; 117(Pt 24):5749-57. PubMed ID: 15507482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
    Winqvist I; Olofsson T; Olsson I
    Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells.
    Tohma S; Lipsky PE
    J Immunol; 1991 Apr; 146(8):2544-52. PubMed ID: 1707911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
    Egesten A; Malm J
    Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins.
    Egesten A; Gullberg U; Olsson I; Richter J
    J Leukoc Biol; 1993 Mar; 53(3):287-93. PubMed ID: 8095965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.